CID 170311

Dribendazole

Structural Information

Molecular Formula
C15H19N3O2S
SMILES
COC(=O)NC1=NC2=C(N1)C=C(C=C2)SC3CCCCC3
InChI
InChI=1S/C15H19N3O2S/c1-20-15(19)18-14-16-12-8-7-11(9-13(12)17-14)21-10-5-3-2-4-6-10/h7-10H,2-6H2,1H3,(H2,16,17,18,19)
InChIKey
LRPJFWDUBNJJKE-UHFFFAOYSA-N
Compound name
methyl N-(6-cyclohexylsulfanyl-1H-benzimidazol-2-yl)carbamate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

147
Patents

305.1198 Da
Monoisotopic Mass

3.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 306.12708 167.8
[M+Na]+ 328.10902 174.3
[M-H]- 304.11252 171.2
[M+NH4]+ 323.15362 182.5
[M+K]+ 344.08296 169.3
[M+H-H2O]+ 288.11706 160.1
[M+HCOO]- 350.11800 181.4
[M+CH3COO]- 364.13365 177.7
[M+Na-2H]- 326.09447 169.2
[M]+ 305.11925 167.4
[M]- 305.12035 167.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe